AXOGEN INC's ticker is AXGN and the CUSIP is 05463X106. A total of 119 filers reported holding AXOGEN INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $705,000 | -42.8% | 67,765 | -1.6% | 0.00% | 0.0% |
| Q4 2019 | $1,232,000 | +42.1% | 68,839 | -0.9% | 0.00% | 0.0% |
| Q3 2019 | $867,000 | -74.7% | 69,461 | -59.9% | 0.00% | -66.7% |
| Q2 2019 | $3,427,000 | -7.0% | 173,093 | -1.0% | 0.00% | -25.0% |
| Q1 2019 | $3,683,000 | -13.4% | 174,881 | -16.0% | 0.00% | -20.0% |
| Q4 2018 | $4,251,000 | -45.2% | 208,095 | -1.2% | 0.01% | -28.6% |
| Q3 2018 | $7,760,000 | -12.5% | 210,578 | +19.4% | 0.01% | -22.2% |
| Q2 2018 | $8,864,000 | +4.6% | 176,402 | -24.0% | 0.01% | +12.5% |
| Q1 2018 | $8,476,000 | +17.2% | 232,228 | -9.1% | 0.01% | +33.3% |
| Q4 2017 | $7,232,000 | +43.5% | 255,561 | -1.9% | 0.01% | +50.0% |
| Q3 2017 | $5,040,000 | +16.9% | 260,484 | +1.2% | 0.00% | 0.0% |
| Q2 2017 | $4,313,000 | +56.6% | 257,505 | -2.3% | 0.00% | +33.3% |
| Q1 2017 | $2,754,000 | +18.0% | 263,520 | +1.6% | 0.00% | +50.0% |
| Q4 2016 | $2,334,000 | -14.2% | 259,279 | -13.9% | 0.00% | -33.3% |
| Q3 2016 | $2,720,000 | – | 301,185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,981,888 | $23,049,000 | 12.25% |
| PERKINS CAPITAL MANAGEMENT INC | 286,190 | $3,328,000 | 3.06% |
| First Light Asset Management, LLC | 1,729,435 | $20,113,000 | 2.06% |
| G2 Investment Partners Management LLC | 594,672 | $6,916,000 | 1.67% |
| Genesee Capital Advisors, LLC | 148,913 | $1,731,000 | 1.43% |
| Soleus Capital Management, L.P. | 135,111 | $1,571,000 | 0.83% |
| ArrowMark Colorado Holdings LLC | 6,590,624 | $76,649,000 | 0.73% |
| Parkman Healthcare Partners LLC | 125,000 | $1,454,000 | 0.38% |
| Granite Point Capital Management, L.P. | 580,739 | $6,754,000 | 0.37% |
| Endurant Capital Management LP | 70,209 | $817,000 | 0.24% |